Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

CS MEDICA A/S: Statement of Extraordinary General Meeting

Read the release

Today on April 14, 2023, in Copenhagen - CS MEDICA A/S ("CS MEDICA" or "The Company") held an extraordinary general meeting ("EGM") at which the following principal resolutions were passed.

Approval of the first proposal to make a cash capital increase (direct issue) of 2,132,954 new shares at a price of DKK 28.13 per share.
The EGM resolved in accordance with the Board of Directors' proposal to make a cash capital increase (direct issue) to be subscribed by Inner Mongolia RongShi Hi-Tech Co., Ltd.("RongShi") of 2,132,954 shares at a price of DKK 28.13 per share, without pre-emption right for the existing shareholders.

Approval of the second proposal authorizing the board of directors to issue 2,132,954 shares to RongShi.
The EGM resolved in accordance with the Board of Directors' proposal to authorize the board of directors to issue the shares to RongShi under the described terms. The authorization is valid for a period of five years from the date of the extraordinary general meeting.

The total number of votes as of the date of this Statement is 12,322,635, whereof 66,2%, equal to 8.154,509, votes was represented at the EGM.

The resolutions were approved unanimously by all shareholders represented at the EGM.

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.